Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Peptide Synthesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101357937A details an efficient Fmoc-based SPPS route for Atosiban, offering high purity and reduced waste for pharmaceutical manufacturing.
Discover the patented preparation of alpha-chlorinated carbonates for amino acid protection. A breakthrough in cost reduction and scalability for pharmaceutical manufacturing.
Novel patent CN109824547A enables safer synthesis of double protected amino acids. Achieve high purity and reduced costs for pharmaceutical intermediate manufacturing supply chains.
Novel fragment method eliminates hydrogenation steps ensuring high purity and cost reduction in pharmaceutical intermediate manufacturing for global supply chains.
Advanced preparation of Desmopressin Acetate via solid-phase synthesis and liquid-phase oxidation. High purity, scalable process for reliable pharmaceutical intermediates supply.
Novel cyclic peptide patent CN109897091A offers high stability against Candida albicans. Reliable supplier for scalable pharmaceutical intermediate manufacturing.
Patent CN113501871B reveals a novel solid-liquid phase method for dasiglucagon. Enhance purity and yield for reliable supply chain integration.
Patent CN104628826A details a high-yield Linaclotide method. This report analyzes supply chain benefits and cost reduction in API manufacturing for procurement teams.
Novel liquid phase method for etelcalcetide intermediate offers high purity and scalability. Reduces purification steps and enhances supply chain reliability for pharmaceutical manufacturing.
Novel patent CN121181646A details high-purity glycylglycylglutamine preparation offering significant supply chain reliability and cost reduction in pharmaceutical manufacturing processes.
Patent CN108484735A details solid-phase synthesis of cyclic heptapeptides. Offers high purity, scalable production, and cost-effective marine drug intermediate manufacturing solutions.
Patent CN103665109B reveals liquid phase synthesis for OGP pentapeptide. Offers cost reduction and scalability for pharmaceutical manufacturing supply chains.
Patent CN118791551B details high-purity semaglutide dipeptide fragment synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediates globally.
Patent CN103554226B details all-solid-phase synthesis for alpha-conotoxin MI. Enhances purity and supply chain reliability for pharmaceutical intermediate manufacturing.
Novel solid-phase method improves purity and yield significantly. Reduces impurities and production costs for scalable manufacturing of cardiovascular drugs.
Patent CN117659159A details a novel solution-phase synthesis for Semaglutide side chains, offering significant cost reduction and supply chain reliability for global buyers.
Patent CN101712716B details a solid-phase iodine oxidation method for Vapreotide, improving yield and purity while simplifying manufacturing for reliable supply chains.
Patent CN104311639A details improved solid-phase synthesis for Somatostatin. Enhances purity and yield while reducing oxidation risks for supply chain stability.
Patent CN102816211B details a high-yield Fmoc solid-phase synthesis for Afamelanotide, offering safer production and cost reduction in pharmaceutical manufacturing.
Patent CN101284862B reveals a novel L-carnosine synthesis route achieving >99.5% purity. Discover cost-effective manufacturing and scalable supply chain solutions.